[
  {
    "ts": null,
    "headline": "CMS decision opens ‘massive’ patient pool for Medtronic, says BTIG",
    "summary": "BTIG analyst Ryan Zimmerman keeps a Neutral rating on Medtronic (MDT) after Centers for Medicare and Medicaid Services provided a proposed national coverage decision for renal denervation. As anticipated, CMS is proposing to cover renal denervation for uncontrolled hypertension, the analyst tells investors in a research note. BTIG says that while the news was expected, it is still a win for Medtronic. The company has been preparing sites for coverage with the launch of Symplicity Spyral, the fir",
    "url": "https://finnhub.io/api/news?id=f692a903aa590261c12210af3f0cf4ff019efe9ec9f78b780d5f943345067274",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752328209,
      "headline": "CMS decision opens ‘massive’ patient pool for Medtronic, says BTIG",
      "id": 135899639,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "BTIG analyst Ryan Zimmerman keeps a Neutral rating on Medtronic (MDT) after Centers for Medicare and Medicaid Services provided a proposed national coverage decision for renal denervation. As anticipated, CMS is proposing to cover renal denervation for uncontrolled hypertension, the analyst tells investors in a research note. BTIG says that while the news was expected, it is still a win for Medtronic. The company has been preparing sites for coverage with the launch of Symplicity Spyral, the fir",
      "url": "https://finnhub.io/api/news?id=f692a903aa590261c12210af3f0cf4ff019efe9ec9f78b780d5f943345067274"
    }
  }
]